Loading…
Codexis, Inc. is projected to rise to $1.49 by 2027, a +7% move from its current price of $1.40. CDXS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $1.34 | $1.40 | $1.46 | +0.06% |
| Aug 5 | $1.32 | $1.40 | $1.49 | +0.12% |
| Aug 6 | $1.30 | $1.40 | $1.51 | +0.18% |
| Aug 7 | $1.29 | $1.40 | $1.53 | +0.25% |
| Aug 8 | $1.28 | $1.40 | $1.54 | +0.31% |
| Aug 9 | $1.27 | $1.41 | $1.56 | +0.37% |
| Aug 10 | $1.26 | $1.41 | $1.57 | +0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.26 | $1.41 | $1.57 | +0.43% |
| Week 2 | $1.20 | $1.41 | $1.66 | +0.87% |
| Week 3 | $1.17 | $1.42 | $1.72 | +1.30% |
| Week 4 | $1.14 | $1.42 | $1.78 | +1.74% |
| Week 5 | $1.11 | $1.43 | $1.84 | +2.18% |
| Week 6 | $1.09 | $1.44 | $1.89 | +2.62% |
| Week 7 | $1.07 | $1.44 | $1.94 | +3.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Codexis, Inc. (CDXS) is a healthcare company that provides technology solutions for therapeutics manufacturing, leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company also develops its ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Codexis, Inc. is a healthcare stock with current price $1.48 and a market cap of $134.53M, ranking 3843 by market capitalization. The near-term picture places the stock in a neutral position given its 30-day technical setup.
The forecasted path shows the long-run price outlook trending higher, with multi-year averages rising toward the end of the forecast horizon.
A major floor 60.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 90.0% above — a clean break opens room to run.
A major ceiling 120.0% above — clearing it would confirm fresh momentum.
Key CDXS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CDXS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.48 | Sell | $1.51 | Sell |
| MA 10 | $1.73 | Sell | $1.68 | Sell |
| MA 20 | $2.06 | Sell | $1.92 | Sell |
| MA 50 | $2.33 | Sell | $2.16 | Sell |
| MA 100 | $2.25 | Sell | $2.17 | Sell |
| MA 200 | $1.97 | Sell | $2.19 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 24.38 | Buy |
| Stoch RSI (14) | 4.97 | Buy |
| CCI (20) | -124.00 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -36.65 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.12 | Sell |
| Awesome (5,34) | -0.72 | Sell |
| Ultimate (7,14,28) | 15.18 | Buy |
| Momentum (10) | -0.84 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 1.34 | Buy |
| ADX (14) | 27.90 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 30. The stock trades with SMA50 at $2.45 and SMA200 at $2.01, with support at $1.99 and resistance at $2.66. The 30-day trading range is $1.17 to $1.87, indicating limited near-term movement.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.98 | $1.40 | $2.03 | 0% | Neutral | |
| $1.13 | $1.49 | $2.12 | +7% | Neutral | |
| $1.24 | $1.72 | $2.58 | +23% | Bullish | |
| $1.20 | $1.73 | $2.70 | +23% | Bullish | |
| $1.03 | $1.53 | $2.47 | +9% | Neutral | |
| $1.30 | $2.00 | $3.33 | +43% | Bullish | |
| $1.58 | $2.51 | $4.29 | +79% | Bullish | |
| $1.66 | $2.71 | $4.74 | +93% | Bullish | |
| $1.70 | $2.85 | $5.09 | +104% | Bullish | |
| $1.52 | $2.63 | $4.80 | +88% | Bullish | |
| $2.25 | $4.41 | $8.75 | +215% | Bullish | |
| $3.15 | $7.01 | $15.63 | +401% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.98 | $1.40 | $1.82 | +0.00% |
| September 2026 | $1.23 | $1.48 | $1.85 | +5.87% |
| October 2026 | $1.22 | $1.48 | $1.88 | -0.10% |
| November 2026 | $1.26 | $1.55 | $1.99 | +4.59% |
| December 2026 | $1.27 | $1.56 | $2.03 | +0.97% |
Click any year to see its month-by-month CDXS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Codexis, Inc.'s 2026 outlook centres on $1.40, within a $0.98 to $2.03 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, CDXS could reach as high as $2.12, with a base case around $1.49 and support toward $1.13 — roughly +7% from $1.40. Price action looks broadly range-bound.
Expect CDXS to range from $1.24 to $2.58 through 2028. The $1.72 average target implies a +23% move from current prices. That is up +15% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The CDXS price prediction for 2029 points to an average of $1.73 (low $1.20, high $2.70) — a potential gain of +23% on today's $1.40. Momentum favours further upside here.
In 2030, CDXS is projected to trade between $1.03 and $2.47, averaging $1.53 — a potential gain of +9% from today's $1.40. That is -11% versus the projected 2029 average. A consolidation phase looks the most probable path here.
Codexis, Inc.'s 2031 outlook centres on $2.00, within a $1.30 to $3.33 range. That is up +31% on the projected 2030 average. That marks a +43% change versus current levels. Momentum favours further upside here.
By 2032, CDXS could reach as high as $4.29, with a base case around $2.51 and support toward $1.58 — roughly +79% from $1.40. Buyers look set to stay in control over this stretch.
Expect CDXS to range from $1.66 to $4.74 through 2033. The $2.71 average target implies a +93% move from current prices. That is up +8% on the projected 2032 average. Momentum favours further upside here.
The CDXS price prediction for 2034 points to an average of $2.85 (low $1.70, high $5.09) — a potential gain of +104% on today's $1.40. Buyers look set to stay in control over this stretch.
In 2035, CDXS is projected to trade between $1.52 and $4.80, averaging $2.63 — a potential gain of +88% from today's $1.40. That is -8% versus the projected 2034 average. Momentum favours further upside here.
Codexis, Inc.'s 2040 outlook centres on $4.41, within a $2.25 to $8.75 range. That is up +68% on the projected 2035 average. That marks a +215% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, CDXS could reach as high as $15.63, with a base case around $7.01 and support toward $3.15 — roughly +401% from $1.40. Momentum favours further upside here.
Investing $1,000 in CDXS today (≈ 714.285714 CDXS) could be worth
$5,007.22
+$4,007.22 (+401%) by 2050 · US Dollar
Based on the average projected CDXS price of $7.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CDXSwould be worth at today's price.
$1,000 invested in CDXS on Jul 31, 2025 (≈ 373.134319 CDXS) would be worth
$522.39
-$477.61 (-47.8%) today · 0.52× · US Dollar
Based on a CDXS entry price of $2.68 vs. today's $1.4.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.48 | $945.95 | -5.4% |
| 1 month ago | $2.39 | $585.77 | -41.4% |
| 3 months ago | $2.67 | $524.34 | -47.6% |
| 6 months ago | $1.44 | $972.22 | -2.8% |
| 1 year ago | $2.68 | $522.39 | -47.8% |
| All time (5.0y) ago | $21.6 | $64.81 | -93.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CDXS forecast.
Our base-case forecast reaches $2.80 around 2034.
Implied market cap at $2.80: $301.17M
The multi-year forecast shows a bullish trajectory, with 2030 averaging $1.94 and a max of $2.99, yielding an ROI of 31.3% and a BULLISH sentiment. By 2040 the forecast projects an average of $6.23 and a max of $11.45, with an ROI of 320.6% and a BULLISH sentiment. By 2050 the average is projected at $10.81 with a max of $22.10, delivering an ROI of 630.5% and a BULLISH sentiment.
These figures illustrate a sustained long-term upward path across the forecast horizon.
Tap a question to reveal the answer.
2030 min $1.37, avg $1.94, max $2.99; ROI 31.3%; sentiment BULLISH.
The forecast shows a bullish path in the long run, with 2030 avg $1.94, 2040 avg $6.23, and 2050 avg $10.81, plus ROIs of 31.3%, 320.6%, and 630.5% respectively, though 2026 is neutral.
Yes. The 2040 max is $11.45 and the 2050 max is $22.10, indicating potential to exceed $11 within the forecast horizon.
Current price is $1.48 and market cap is $134.53M; the asset is ranked 3843.
Sentiment is NEUTRAL with RSI 30. The SMA50 is $2.45, SMA200 is $2.01, with support at $1.99 and resistance at $2.66. The 30-day range is $1.17 to $1.87.
Codexis, Inc. Community Discussion
0Share your Codexis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.